The purpose of this study is to test the safety and effectiveness of a sequence of drugs (a Taxane plus Trastuzumab plus Pertuzumab followed by Trastuzumab Der…

Breast Cancer FemaleBreast CancerBreast Cancer Metastatic+3 more

~Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT06439693

Phase 2

A Phase II Trial to Correlate Early Clinical Response to Pathologic Outcome With Neoadjuvant Systemic Therapy in Patients With Early Stage Breast Cancer

The purpose of this study is to learn whether clinical response (the amount a tumor shrinks based on imaging or tumor measurements obtained by physical exam) p…

Breast CancerBreast NeoplasmBreast Cancer Female+8 more

~Estimated

~$10 – $7,500

Baylor Breast Care CenterNCT05020860